Table 1.
Variable | No. of failure/total patients | P-value |
Distribution of telangiectasias | ||
Distal rectum (within 10 cm from anal verge) | 7/31 | 0.1361 |
Entire rectum +/− sigmoid (more than 10 cm from anal verge) | 7/14 | |
Surface area covered by telangiectasias | ||
Less than 50% | 2/19 | 0.0112 |
More than 50% | 12/26 | |
Presence of fresh blood | ||
No | 3/16 | 0.3201 |
Yes | 11/29 | |
Ulceration | ||
< 1 cm2 | 6/33 | 0.0061 |
> 1 cm2 | 8/12 | |
Gender | ||
Female | 14/40 | 0.3053 |
Male | 0/5 | |
Hypertensive | ||
No | 11/39 | 0.3563 |
Yes | 3/6 | |
Diabetic | ||
No | 11/40 | 0.1663 |
Yes | 3/5 | |
Abdominal surgery | ||
No | 11/33 | 0.8651 |
Yes | 3/12 | |
Acute radiation injury | ||
No | 14/39 | 0.1563 |
Yes | 0/6 | |
Requiring blood transfusions | ||
No | 7/30 | 0.2101 |
Yes | 7/15 | |
Number of APC | ||
1 | 11/33 | 0.8651 |
≥ 2 | 3/12 | |
Age, yr | ||
< 60 | 8/22 | 0.4572 |
≥ 60 | 6/23 | |
BMI at the first treatment of APC, kg/m2 | ||
< 21 | 7/21 | 0.7632 |
≥ 21 | 7/24 | |
Time from the end of radiotherapy to bleeding, mo | ||
< 8 | 6/17 | 0.6372 |
≥ 8 | 8/28 | |
Time from the end of radiotherapy to the first time of APC, mo | ||
< 14 | 8/23 | 0.5862 |
≥ 14 | 6/22 |
Data were calculated using continuity correction;
Data were calculated using the χ2 test;
Data were calculated using the Fisher exact test.
APC: Argon plasma coagulation; CRP: Chronic radiation proctitis; BMI: Body mass index.